Real-time enrollment status for this gaucher disease type 1 clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:43 PM UTC
| NCT Number | NCT07223944 |
| Recruiting Status | Recruiting |
| Condition | Gaucher Disease Type 1 |
| Phase | PHASE3 |
| Target Enrollment | 45 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Spur Therapeutics |
| Last Updated on CT.gov | September 3, 2026 (Sep 3, 2026) |
As of October 12, 2026: Clinical trial NCT07223944 is currently recruiting participants. This phase3 study for gaucher disease type 1 is actively seeking new participants at 16 locations across the United States. The study is sponsored by Spur Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07223944 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07223944 was last updated Sep 3, 2026 (September 3, 2026). HelloStudys verifies this status automatically.